𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dietary and stored iron as predictors of breast cancer risk: A nested case–control study in Shanghai

✍ Scribed by Amber B. Moore; Jackilen Shannon; Chu Chen; Johanna W. Lampe; Roberta M. Ray; Sharon K. Lewis; Minggang Lin; Helge Stalsberg; David B. Thomas

Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
102 KB
Volume
125
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Increases in risk of breast cancer in successive generations of migrants to the United States from China and rapid temporal changes in incidence rates in China following social and economic changes clearly implicate environmental factors in the etiology of this disease. Case–control and cohort studies have provided evidence that at least some of these factors may be dietary. Iron, an essential element necessary for cell function, has also been demonstrated to have potential carcinogenic and co‐carcinogenic activities. Iron overload, which was previously uncommon, has become more common in the United States than iron deficiency and may be increasing in China concurrently with dramatic increases in meat consumption. A case–control study nested in a cohort of women in Shanghai, China, was conducted to evaluate possible associations between risk of proliferative and nonproliferative fibrocystic changes as well as breast cancer and dietary iron intake and plasma ferritin levels. Plasma ferritin levels and reported dietary iron intake were compared in 346 women with fibrocystic changes, 248 breast cancer cases and 1,040 controls. Increasing ferritin levels were significantly associated with increasing risk of nonproliferative fibrocystic changes (OR: 2.51, 95% CI: 1.16–5.45, p trend = 0.04). Similar, but weaker, trends were observed for proliferative changes and for breast cancer. Risk of breast cancer relative to the risk of fibrocystic changes was associated with dietary iron intake in women with nonproliferative fibrocystic changes (OR: 2.63, 95% CI: 1.04–6.68, p = 0.02). In conclusion, this study finds significant associations between iron (stored and dietary) and fibrocystic disease and breast cancer. © 2009 UICC

📜 SIMILAR VOLUMES

Iron intake, body iron stores and colore
Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study
✍ Ikuko Kato; Ann M. Dnistrian; Morton Schwartz; Paolo Toniolo; Karen Koenig; Roy 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 57 KB 👁 3 views

Accumulated evidence suggests that increased body iron stores may increase the risk of colorectal cancer, possibly via catalyzing oxidation reactions. We examined the relationship between iron status and colorectal cancer in a case-control study nested within the New York University Women's Health S

Dietary and other risk factors in women
Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: A nested case-control study in Shanghai, China
✍ Wenjin Li; Roberta M. Ray; Johanna W. Lampe; Ming-Gang Lin; Dao Li Gao; Chunyuan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 188 KB 👁 1 views

## Abstract Risk of breast cancer is increased in women with proliferative benign breast conditions. Most of these conditions, however, do not progress to breast cancer. The purpose of our study was to identify factors possibly associated with this progression. Women with proliferative fibrocystic

Dietary phytoestrogen intake and premeno
Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study
✍ Jakob Linseisen; Regina Piller; Silke Hermann; Jenny Chang-Claude 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 96 KB 👁 2 views

## Abstract A diet high in isoflavonoids (soy) is associated with lower breast cancer risk in Asian populations. Due to the low soy intake, dietary lignans may be the more important phytoestrogen class in Western populations. We used a population‐based case‐control study of breast cancer by age 50

Serum enterolactone concentration is not
Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study
✍ Annamari Kilkkinen; Jarmo Virtamo; Erkki Vartiainen; Risto Sankila; Mikko J. Vir 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 73 KB 👁 2 views

## Abstract The lignan enterolactone produced by the intestinal microflora from dietary precursors has been hypothesized to protect against hormone‐dependent cancers. We conducted a nested case‐control study to examine the relationship between serum enterolactone concentration and risk of breast ca

Serum levels of vitamin D, PTH and calci
Serum levels of vitamin D, PTH and calcium and breast cancer risk—a prospective nested case–control study
✍ Martin Almquist; Anne-Greth Bondeson; Lennart Bondeson; Johan Malm; Jonas Manjer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 176 KB 👁 1 views

## Abstract Previous studies indicate that calcium and its regulating hormones, __i.e__., parathyroid hormone (PTH) and vitamin D, might affect breast cancer risk. Evidence also suggests that this relationship could be influenced by menopausal status and BMI. We examined breast cancer risk related